Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New wireless patch could spot Post-Surgery trouble early

NCT ID NCT06574867

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new wireless device called viQtor that continuously tracks vital signs like heart rate and breathing in 500 patients after surgery. The goal was to see if it helps nurses catch problems earlier and reduces the need for manual checks. The device was used on a surgical ward in the Netherlands over 7 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

500 people

The number who actually took part.

Started

Oct 2024

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of adult post-operative patients admitted to the surgical ward at Catharina Hospital Eindhoven. The study will focus on evaluating the feasibility and effectiveness of continuous vital sign monitoring using the viQtor device.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients (18 years and older). * Patients admitted to the surgical ward at Catharina Hospital Eindhoven. * Fluent in Dutch or English. * Willingness to participate in the study and to wear the viQtor monitoring device during their hospital stay. Exclusion Criteria: Patients with cognitive impairments. * Patients with allergies to metal or plastics. * Patients with significant deformities, swelling, irritation, degenerative changes, or edema of the upper arm. * Patients with implanted cardiac pacemakers, internal cardioverter defibrillators, or chronic resynchronization therapy devices. * Patients at risk of vascular compromise of the arm on which the device will be placed. * Patients with conditions that contraindicate the use of a blood pressure cuff or similar devices.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Contiuous vital signs monitoring are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Catharina Hospital Eindhoven

    Eindhoven, North Brabant, 5623EJ, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.